D-0831-2020 Class II Terminated
FDA drug recall D-0831-2020 was initiated by Teva Pharmaceuticals USA on Jan 27, 2020 and is designated Class II. Reason for recall: GMP Deviations: Product bottle may be absent of desiccant. The recall status is terminated (terminated Dec 10, 2020). Affected quantity: 69,012 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 12, 2020
- Initiation Date
- Jan 27, 2020
- Termination Date
- Dec 10, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 69,012 bottles
Product description
Desmopressin Acetate Tablets, 0.2 mg, 100-count bottle, Rx Only, Manufactured by: Actavis Laboratories, Inc. Fort Lauderdale, FL 33314 USA, Distributed by: Actavis Pharma, Inc. Parisppany, NJ 07054 USA, NDC 0591-2465-01
Reason for recall
GMP Deviations: Product bottle may be absent of desiccant.
Distribution pattern
Nationwide within the United States
Code information
Lot #: 1269726M, exp. date 01/2020; 1283269M, 1283270M, exp. date 03/2020; 1292992M,1292993A, exp. date 04/2020
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0831-2020
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026